Profile
Thibaut Roulon is currently Director at Depixus SAS, Nouscom AG, LimFlow SA, AlgoTherapeutix SAS, Imcheck Therapeutics SAS (since 2019), NH TherAguix SAS (since 2019), and Investment Director at BPIFrance Investissement SAS (since 2010).
Also holds positions as Member-Supervisory Board at ADEMTECH SA and Step Pharma SAS. Former roles include Director at Poxel SA, Sangamo Therapeutics France SAS, Sensorion SA, Biom'Up SA, Gensight Biologics SA, GamaMabs Pharma SA, CorWave SA; Independent Director at Advicenne SA from 2011 to 2026; and Chargé d'Affaires at Bioam Gestion SA from 2005 to 2010.
Education includes undergraduate degree from École Centrale Paris and doctorate from Université Pierre et Marie Curie.
Thibaut Roulon active positions
| Companies | Position | Start |
|---|---|---|
| NH THERAGUIX SAS | Director/Board Member | 22/02/2019 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Director/Board Member | - |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services Specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications | Director/Board Member | - |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology Develops medical devices for the treatment of CLTI | Director/Board Member | - |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Director/Board Member | - |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Director/Board Member | 04/12/2019 |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Director/Board Member | - |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Private Equity Analyst | 14/10/2010 |
Depixus SAS
Depixus SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops a technology for genetic and epigenetic analysis | Director/Board Member | - |
Former positions of Thibaut Roulon
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Thibaut Roulon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Bioam Gestion SA
Bioam Gestion SA Investment ManagersFinance BG is a venture capital investment management firm specialized in early-stage financing of biotechnology companies. They target start-ups with high growth potential, spawned by French and European public or private sector life science research, and more particularly applications in the healthcare, environment, agricultural and food industries. Within the healthcare sector BG focuses on biopharmaceuticals, medical instrumentation and diagnosis systems. BG provides seed capital, generally investing in the first institutional round of financing, and later participating in subsequent rounds. The firm usually joins forces with French or foreign co-investors. BG invests in France and in Europe. The firm sources deals through their extensive network in the French academic community and in the biopharmaceutical industry. BG is an active investor who sits on the board and provides strategic advisory as well as development assistance to their portfolio companies. | Finance |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services Specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications | Commercial Services |
École Centrale Paris
École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Finance |
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Biom'Up SA
Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Advicenne SA
Advicenne SA Pharmaceuticals: GenericHealth Technology Develops and markets pediatric drugs | Health Technology |
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services Specializes in developing monoclonal antibodies | Health Services |
CorWave SA
CorWave SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures blood pumps | Commercial Services |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology Develops medical devices for the treatment of CLTI | Health Technology |
Depixus SAS
Depixus SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops a technology for genetic and epigenetic analysis | Commercial Services |
NH TherAguix SAS
NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Health Technology |
- Stock Market
- Insiders
- Thibaut Roulon
















